{"id":900,"date":"2003-07-01T12:00:00","date_gmt":"2003-07-01T10:00:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2003\/neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie"},"modified":"2022-03-17T14:10:27","modified_gmt":"2022-03-17T13:10:27","slug":"neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2003\/neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie","title":{"rendered":"Neue Empfehlungen zur Behandlung der arteriellen Hypertonie"},"content":{"rendered":"<p>K\u00fcrzlich ist der 7. Report des US Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) erschienen (1). \u00dcber den Vorg\u00e4nger-Report (JNC VI) haben wir 1997 ausf\u00fchrlich berichtet (2). In der Zwischenzeit sind mehrere wichtige klinische Studien zur Behandlung der Hypertonie und zu Erkrankungen, die sie h\u00e4ufig begleiten (Herzinsuffizienz, [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>K\u00fcrzlich ist der 7. Report des US Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) erschienen (1). \u00dcber den Vorg\u00e4nger-Report (JNC VI) haben wir 1997 ausf\u00fchrlich berichtet (2). In der Zwischenzeit sind mehrere wichtige klinische Studien zur Behandlung der Hypertonie und zu Erkrankungen, die sie h\u00e4ufig begleiten (Herzinsuffizienz, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[130,1159,1426,316,309,312,314,313,315,317,320,311,307,319,310,129,128,131,324,1944,322,492,323,1160,325,134,1530,1533,1161,1484,1482,1483,2311,306,579,437,1158],"class_list":["post-900","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-ace-hemmer","tag-adipositas","tag-alkohol","tag-angiotensin-ii-antagonisten","tag-angiotensin-ii-blocker","tag-angiotensin-ii-inhibitoren","tag-angiotensin-ii-rezeptor-antagonisten","tag-angiotensin-ii-rezeptor-blocker","tag-angiotensin-ii-rezeptor-inhibitoren","tag-at-ii-antagonisten","tag-at-ii-blocker","tag-at-ii-inhibitoren","tag-at-ii-rezeptor-antagonisten","tag-at-ii-rezeptor-blocker","tag-at-ii-rezeptor-inhibitoren","tag-beta-blocker","tag-betablocker","tag-betarezeptoren-blocker","tag-blutdruck","tag-dash-diaet","tag-diaet","tag-diuretika","tag-ernaehrung","tag-gewichtsreduktion","tag-hypertonie","tag-kalziumantagonisten","tag-kochsalz","tag-kochsalzreduktion","tag-koerpergewicht","tag-koerperliche-aktivitaet","tag-lebensstil","tag-lifestyle","tag-salzreduktion","tag-sartane","tag-spironolacton","tag-thiazide","tag-uebergewicht"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/900","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=900"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/900\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=900"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=900"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=900"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}